dpp-4 inhibitor and glp-1 receptor agonist combination not recommended guideline Clinical Use of Inhibitors The pharmacology of DPP-4 inhibitors

Any comparison of their magnitudes is inference across unlike studies, which cannot establish superiority

Holding the syringe at a 45-degree angle, we insert the needle just under the skin

AbdolSamad Abedi: Writing original draft (equal)

Concurrently, novel investigations are exploring targeted microbial therapies, including probiotics, prebiotics, and fecal microbiota transplantation (FMT), to optimize therapeutic outcomes for PCOS patients ( Figure 4 , Table 2 )

These include the following: Medullary carcinoma of thyroid (MTC) and Multiple Endocrine Neoplasia type 2 syndrome (MEN 2): Semaglutide is contraindicated in patients with a personal or family history of thyroid tumors, particularly medullary thyroid carcinoma (MTC) and Multiple Endocrine Neoplasia type 2 syndrome (MEN 2)

Understanding Diabetic Acute Kidney Disease and the Role of GLP-1 RAs Diabetic kidney disease (DKD) is a common yet challenging complication of diabetes, often leading to chronic kidney damage, cardiovascular issues, and even end-stage renal disease (ESRD) if left untreated